This site uses features not supported by Internet Explorer.

Onglyza

Prescribed to treat type 2 diabetes, the AstaZeneca/Bristol-Meyers Squibb drug Onglyza mimics hormones to trigger insulin release. The FDA has required label warnings about an increased risk for acute pancreatitis. In 2013, the Journal of the American Medical Association reported a substantially increased risk for pancreatic cancer with the drug. The FDA has also required a warning label about increased risk for heart failure.

CAMG has thousands of spots and infomercials that can be branded for your firm. Reach out to us for the latest creative offline and online examples*.
*Examples shown are not always current examples.

Request Samples

* These fields are required.

Media landscape article card pevnw7

The 2021 Media Landscape: What’s Ahead?

Plan your 2021 marketing with our exclusive media forecast.

Access here

Bosco shots r2qk f8t mb rw unsplash o3ibqc

CAMG Ethics White Paper

Get access to our exclusive White Paper and State Ethics Database.

Get it now!